Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours

被引：0
|
作者：
Roberto, M. [1 ]
Arrivi, G. [2 ]
Milano, A. [1 ]
D'Antonio, C. [1 ]
Romiti, A. [3 ]
Falcone, R. [1 ]
Mazzuca, F. [1 ]
Fais, S. [4 ]
Marchetti, P. [1 ]
机构：
[1] Univ Roma La Sapienza, St Andrea Hosp, Rome, Italy
[2] St Andrea Hosp, Rome, Italy
[3] Univ Roma La Sapienza, St Andrea Hosp, Oncol Dept, Rome, Italy
[4] Ist Super Sanita, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 160
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase I/II trial of dose reduced capecitabine in elderly or frail patients with untreated advanced colorectal cancer.
    Breadner, Daniel Adam
    Welch, Stephen
    Jonker, Derek J.
    Klimo, Paul
    Cripps, M. Christine
    Biagi, James Joseph
    Lam, Wendy
    Whiston, Frances
    Stitt, Larry
    Vincent, Mark David
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [32] Updated results of a randomized phase II trial for neoadjuvant versus adjuvant docetaxel/cisplatin chemotherapy in patients with locally advanced gastric cancer.
    Kim, Young Woo
    Ryu, Keun Won
    Choi, Il Ju
    Kook, Myeong-Cherl
    Park, Young Iee
    Kim, Hark K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [33] High-dose proton beam radiotherapy of hepatocellular carcinoma: Preliminary results of a phase II trial
    Bush, DA
    Hillebrand, DJ
    Slater, JM
    Slater, JD
    GASTROENTEROLOGY, 2004, 127 (05) : S189 - S193
  • [34] Capecitabine in combination with oxaliplatin or with irinotecan in elderly patients with advanced colorectal cancer: Preliminary results of a randomized phase ii study
    Rosati, G.
    Cordio, S.
    Bordonaro, R.
    Gebbia, V.
    Borsellino, N.
    Giannitto, G.
    Rinaldi, A.
    Reggiardo, G.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 20 - 20
  • [35] Capecitabine in combination with oxaliplatin or with irinotecan in elderly patients with advanced colorectal cancer: Preliminary results of a randomized phase II study
    Rosati, G.
    Cordio, S.
    Bordonaro, R.
    Gebbia, V
    Rinaldi, A.
    Giannitto, G.
    Borsellino, N.
    Reggiardo, G.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 189 - 189
  • [36] Capecitabine in combination with oxaliplatin or with irinotecan in elderly patients with advanced colorectal cancer: Preliminary results of a randomized phase II study
    Rosati, G.
    Cordio, S.
    Bordonaro, R.
    Gebbia, V
    Rinalci, A.
    Giannitto, G.
    Borsellino, N.
    Reggiardo, G.
    ANNALS OF ONCOLOGY, 2007, 18 : VII28 - VII29
  • [37] Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial
    Verschuur, Arnauld C.
    Bajciova, Viera
    Mascarenhas, Leo
    Khosravan, Reza
    Lin, Xun
    Ingrosso, Antonella
    Janeway, Katherine A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (01) : 41 - 50
  • [38] Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial
    Arnauld C. Verschuur
    Viera Bajčiová
    Leo Mascarenhas
    Reza Khosravan
    Xun Lin
    Antonella Ingrosso
    Katherine A. Janeway
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 41 - 50
  • [39] Venetoclax Plus High-Dose Cytarabine and Mitoxantrone (HAM-Ven) As Salvage Treatment for Relapsed/Refractory AML: Updated Results of the Phase-I/II SAL Relax Trial
    Ruhnke, Leo
    Schliemann, Christoph
    Mikesch, Jan-Henrik
    Stelljes, Matthias
    Fransecky, Lars
    Steffen, Bjoern
    Kaufmann, Martin
    Burchert, Andreas
    Rank, Andreas
    Hanoun, Maher
    Hoellein, Alexander
    Kraus, Sabrina
    Haenel, Mathias
    Schaefer-Eckart, Kerstin
    Haake, Annett
    Fiebig, Frank
    Zukunft, Sven
    Middeke, Jan Moritz
    Kunadt, Desiree
    Schetelig, Johannes
    von Bonin, Malte
    Roehnert, Maximilian Alexander
    Oelschlaegel, Uta
    Stoelzel, Friedrich
    Baldus, Claudia D.
    Serve, Hubert
    Wermke, Martin
    Bornhaeuser, Martin
    Roellig, Christoph
    BLOOD, 2023, 142
  • [40] Dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab as salvage treatment for patients with refractory or relapsed aggressive non-Hodgkin's lymphoma: Updated results of a multicenter phase II trial.
    Mey, UJM
    Flieger, D
    Birkmann, J
    Neubauer, A
    Ho, AD
    Kaiser, U
    Wilhelm, M
    Haarmann, G
    Hahn, C
    Strehl, JW
    Glasmacher, AG
    Schmidt-Wolf, IGH
    BLOOD, 2003, 102 (11) : 300B - 301B
12345